CYTK Smart Money
Cytokinetics, Incorporated
1W: -3.8%
1M: -7.0%
3M: -21.5%
YTD: -0.3%
1Y: +6.4%
3Y: +85.8%
5Y: +74.2%
$61.52
+0.79 (+1.30%)
Weekly Expected Move ±4.2%
$56
$59
$61
$64
$66
Credit Risk of going bust: lower than 65% of companies Debt: 12.9% of company value Bonds: $54.9M held by 45 funds → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.74 (down 99%), Cytokinetics, Incorporated would be worth roughly what it owes.
Total debt $1.27B against a stock market value of $8.55B.
Distance to default 6.88 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $587.2M (short-term plus half of long-term), stock volatility 42.0%; Altman Z'' -6.09. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $0.74 (down 99%), Cytokinetics, Incorporated would be worth roughly what it owes.
Total debt $1.27B against a stock market value of $8.55B.
Distance to default 6.88 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $587.2M (short-term plus half of long-term), stock volatility 42.0%; Altman Z'' -6.09. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026539
Institutions Holding
+31 vs prior
140.3%
Ownership
+42.58%
95
New
236
Increased
150
Reduced
48
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-20 | Malik Fady Ibraham | officer: evp research & development | S-Sale | 3,500 | $64.01 | $224K | Filing |
| 2026-10-16 | Kaye Edward M. MD | director | A-Grant/Award | 195 | $63.92 | $12K | Filing |
| 2026-10-16 | Wysenski Nancy | director | A-Grant/Award | 97 | $63.92 | $6K | Filing |
| 2026-10-16 | HENDERSON JOHN T | director | A-Grant/Award | 352 | $63.92 | $22K | Filing |
| 2026-10-16 | WIERENGA WENDELL | director | A-Grant/Award | 97 | $63.92 | $6K | Filing |
| 2026-10-16 | Daly James M | director | A-Grant/Award | 195 | $63.92 | $12K | Filing |
| 2026-10-16 | Harrington Robert Arthur | director | A-Grant/Award | 195 | $63.92 | $12K | Filing |
| 2026-10-12 | Blum Robert I | officer: president & ceo | S-Sale | 7,500 | $62.88 | $472K | Filing |
| 2026-10-06 | Malik Fady Ibraham | officer: evp research & development | S-Sale | 3,500 | $61.38 | $215K | Filing |
| 2026-09-28 | Blum Robert I | officer: president & ceo | S-Sale | 7,500 | $65.46 | $491K | Filing |
| 2026-09-22 | Malik Fady Ibraham | officer: evp research & development | S-Sale | 3,500 | $68.29 | $239K | Filing |
| 2026-09-15 | Blum Robert I | officer: president & ceo | S-Sale | 97,926 | $69.33 | $6.8M | Filing |
| 2026-09-15 | Landry Robert E | director | S-Sale | 1,000 | $72.13 | $72K | Filing |
| 2026-09-14 | Blum Robert I | officer: president & ceo | G-Gift | 97,926 | $— | $0 | Filing |
| 2026-09-14 | Blum Robert I | officer: president & ceo | G-Gift | 1,350 | $— | $0 | Filing |
| 2026-09-14 | Blum Robert I | officer: president & ceo | S-Sale | 7,500 | $73.44 | $551K | Filing |
| 2026-09-11 | Landry Robert E | director | S-Sale | 1,000 | $74.66 | $75K | Filing |
| 2026-09-08 | Malik Fady Ibraham | officer: evp research & development | S-Sale | 3,500 | $75.46 | $264K | Filing |
| 2026-09-01 | PARSHALL B LYNNE | director | S-Sale | 5,000 | $71.48 | $357K | Filing |
| 2026-08-31 | Callos Andrew | officer: evp, chief commercial officer | S-Sale | 10,000 | $70.24 | $702K | Filing |
| 2026-08-31 | Blum Robert I | officer: president & ceo | S-Sale | 7,500 | $70.24 | $527K | Filing |
| 2026-08-18 | Malik Fady Ibraham | officer: evp research & development | S-Sale | 3,500 | $75.82 | $265K | Filing |
| 2026-08-10 | Blum Robert I | officer: president & ceo | S-Sale | 7,500 | $76.76 | $576K | Filing |
| 2026-07-30 | Callos Andrew | officer: evp, chief commercial officer | S-Sale | 14,000 | $79.88 | $1.1M | Filing |
| 2026-07-27 | Blum Robert I | officer: president & ceo | S-Sale | 7,500 | $80.87 | $607K | Filing |
🏛️ Congressional Trades
10 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| 2026-09-29 | Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Filing |
| 2026-09-29 | Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Filing |
| 2026-06-30 | Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Filing |
| 2026-06-30 | Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Filing |
| 2026-06-29 | Gilbert Ray Cisneros | House | Buy | $1,001 - $15,000 | Filing |
| 2025-10-08 | Gilbert Ray Cisneros | House | Buy | $1,001 - $15,000 | Filing |
| 2025-06-17 | Lisa McClain | House | Sell | $1,001 - $15,000 | Filing |
| 2025-06-16 | Lisa C. McClain | House | Sell | $1,001 - $15,000 | Filing |
| 2025-06-11 | Lisa McClain | House | Buy | $1,001 - $15,000 | Filing |
| 2025-06-10 | Lisa C. McClain | House | Buy | $1,001 - $15,000 | Filing |
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 20,094,362 | $1.7B | +3,546,351 | 2026-06-30 | Filing |
| WELLINGTON MANAGEMENT GROUP LLP | 6,931,770 | $591M | -1,077,719 | 2026-06-30 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6,711,799 | $572M | +868,017 | 2026-06-30 | Filing |
| STATE STREET CORP | 6,494,233 | $553M | +749,040 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 6,117,515 | $521M | +628,881 | 2026-06-30 | Filing |
| FMR LLC | 5,031,782 | $429M | -5,691,358 | 2026-06-30 | Filing |
| Avoro Capital Advisors LLC | 4,999,999 | $426M | +1,666,666 | 2026-06-30 | Filing |
| BANK OF AMERICA CORP /DE | 4,635,709 | $395M | +1,510,273 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 3,712,501 | $316M | +497,086 | 2026-06-30 | Filing |
| RTW INVESTMENTS, LP | 2,862,003 | $244M | +140,845 | 2026-06-30 | Filing |
| Polar Capital Holdings Plc | 2,253,649 | $192M | +592,401 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 1,761,588 | $150M | -444,170 | 2026-06-30 | Filing |
| Capital Research Global Investors | 1,686,625 | $144M | +915,626 | 2026-06-30 | Filing |
| NORTHERN TRUST CORP | 1,647,345 | $140M | +205,711 | 2026-06-30 | Filing |
| JPMORGAN CHASE & CO | 1,588,895 | $139M | +685,090 | 2026-06-30 | Filing |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1,603,442 | $137M | +515,851 | 2026-06-30 | Filing |
| Integral Health Asset Management, LLC | 1,600,000 | $136M | — | 2026-06-30 | Filing |
| Point72 Asset Management, L.P. | 1,587,712 | $135M | +961,610 | 2026-06-30 | Filing |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,565,781 | $133M | +168,736 | 2026-06-30 | Filing |
| Sixth Street Partners Management Company | 1,565,781 | $133M | +1,565,781 | 2026-06-30 | Filing |